20 results
Thumbnail

- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells

Thumbnail

- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study

Thumbnail

- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib

Thumbnail

- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series

Thumbnail

- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis

Thumbnail

D3.430 - The effect of biological treatment of atopic dermatitis in children

Thumbnail

D3.431 - Dupilumab therapy of patients with chronic rhinosinusitis with nasal polyps: long-term observational study

Thumbnail

D3.432 - Severe chronic rhinosinusitis - diagnostic and therapeutic challenges, personalized approach and place of biological treatment: a clinical case

Thumbnail

D3.433 - An effect on lipid profile of biologic therapy independent from weight variation

Thumbnail

D3.434 - Effectiveness of Biologic Therapies in Adults With Chronic Rhinosinusitis With Nasal Polyps: Real-World Data

Thumbnail

D3.435 - “Looking Twice in Atopic Dermatitis Therapy: Pruritus Is Not Always the Same, and Eczema Is Not Always Atopic Dermatitis”

Thumbnail

- D3.519 - Post-COVID-19 Reshaping of Molecular IgE Sensitization Profiles to Seasonal and Indoor Allergens

Thumbnail

- D3.520 - Post-COVID Olfactory and Taste Dysfunction in Students at a South African Medical School

Thumbnail

D3.521 - Dermatologic adverse effects of COVID-19 vaccination

Thumbnail

- D3.522 - Post-Vaccination SARS-CoV-2 Infections: Evidence, Severity, and Outcomes

Thumbnail

D3.523 - Early childhood: a risk predictor for post-COVID-19 pulmonary sequelae in children

Thumbnail

- D3.524 - Clinical use of procalcitonin and IL-6 in diagnosis of bacterial superinfection in COVID-19

Thumbnail

- D3.525 - One- year hospital readmission after pediatric COVID- 19 hospitalization: a single- center cohort study

Thumbnail

- D3.526 - Baseline demographic characteristics and early-life exposures in infants born during and after the COVID-19 pandemic: A comparison of the CORAL and FLORAL birth cohorts

Thumbnail

- D3.527 - Multisystem Inflammatory Syndrome in Children (MIS-C) as a Condition Resulting from Immune Dysregulation: What has Coronavirus Infection Taught Us? (Case Study)